Crescent Capital Consulting’s Moderna MRNA Stock Holding History

Crescent Capital Consulting’s Portfolio MRNA Stock Details MRNA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$339K	Buy
2021 Q3	$436K	Sell
2021 Q2	$402K	Buy
2021 Q1	$199K	Sell
2020 Q4	$159K	Buy